Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,704.00    46.00 (1.73%)
Bid:
2,697.00
Ask:
2,698.00
Spread: 1.00 (0.037%)
Market Cap: £27.19b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Director/PDMR Shareholding

10 Jun 2014 15:59

RNS Number : 2959J
3i Group PLC
10 June 2014
 



UK Listing Authority Disclosure Rules and Transparency Rules

 

DTR 3.1.4R

 

On 9 June 2014, 3i Group plc (the "Company") was notified of the following. On 6 June 2014 share awards under the 3i Group Deferred Bonus Plan held by the persons discharging managerial responsibilities named in the table below vested. On that date the ordinary shares of 73 19/22p each in the Company ("Shares") shown in the column headed "Shares acquired" were either acquired by the person named or ceased to be subject to restrictions under the Plan. The Shares shown in the column headed "Shares sold" were sold on that date at a price of £4.2932 per share to cover tax and National Insurance payable on the award vesting.

 

 

PDMR

Shares acquired

Shares sold

M A Antal

59,547

31,074

K J Dunn

13,939

6,575

J R Ghose

21,745

10,256

A C B Giddins

59,547

28,086

N E King

5,367

2,532

B R Loomes

21,605

10,190

P J White

6,958

3,282

 

The place of this transaction was the London Stock Exchange.

 

Ends 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUBAQUPCGCU
Date   Source Headline
4th Jan 20234:41 pmRNSDirector/PDMR Shareholding
3rd Jan 20239:25 amRNSPortfolio Update
30th Dec 20228:10 amRNSDirector Declaration
20th Dec 202210:54 amRNSHolding(s) in Company
19th Dec 20222:52 pmRNSHolding(s) in Company
9th Dec 202212:04 pmRNSBlock listing Interim Review
7th Dec 202212:09 pmRNSAdditional Listing
2nd Dec 202210:51 amRNSHolding(s) in Company
30th Nov 20224:15 pmRNSTotal Voting Rights
30th Nov 20224:09 pmRNSDirector/PDMR Shareholding
10th Nov 20229:02 amRNSDoc re. Half Yearly Report 2022
10th Nov 20227:00 amRNSResults for the six months to 30 September 2022
31st Oct 20224:14 pmRNSTotal Voting Rights
31st Oct 20224:14 pmRNSDirector/PDMR Shareholding
4th Oct 20221:08 pmRNSPortfolio Update
30th Sep 20224:08 pmRNSTotal Voting Rights
30th Sep 20224:00 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSUpdate on portfolio and Capital Markets Seminar
31st Aug 20224:07 pmRNSTotal Voting Rights
31st Aug 20224:05 pmRNSDirector/PDMR Shareholding
8th Aug 20222:14 pmRNSDirector/PDMR Shareholding
29th Jul 20225:58 pmRNSDirector/PDMR Shareholding
29th Jul 20225:35 pmRNSTotal Voting Rights
21st Jul 20227:00 amRNSFY2023 Q1 performance update
1st Jul 202211:14 amRNSSection 430 (2B) Companies Act 2006 Statement
1st Jul 202211:04 amRNSPortfolio Update
1st Jul 202210:29 amRNSDirector/PDMR Shareholding
1st Jul 202210:15 amRNSDirector/PDMR Shareholding
30th Jun 20224:27 pmRNSTotal Voting Rights
30th Jun 20222:48 pmRNSDirector/PDMR Shareholding
30th Jun 20222:37 pmRNSResult of AGM
30th Jun 20222:34 pmRNSDoc re. AGM Resolutions
30th Jun 20222:09 pmRNSDirector/PDMR Shareholding
30th Jun 20227:00 amRNSAGM and portfolio update
29th Jun 20223:26 pmRNSDirector/PDMR Shareholding
29th Jun 20222:47 pmRNSDirector/PDMR Shareholding
28th Jun 20224:24 pmRNSDirector/PDMR Shareholding
9th Jun 202212:25 pmRNSBlock listing Interim Review
8th Jun 20222:35 pmRNSDirector/PDMR Shareholding
1st Jun 20221:43 pmRNSDirector/PDMR Shareholding
1st Jun 202212:58 pmRNSDTR 6.3.5
31st May 20223:57 pmRNSTotal Voting Rights
31st May 20223:54 pmRNSDirector/PDMR Shareholding
30th May 20222:20 pmRNSDirector/PDMR Shareholding
26th May 202212:44 pmRNSDoc re. 2022 Notice of AGM
19th May 20221:37 pmRNSDoc re. 2022 Annual Report and Accounts
17th May 20223:19 pmRNSHolding(s) in Company
12th May 20228:50 amRNSDirectorate Change
12th May 20227:00 amRNSResults for the year to 31 March 2022
29th Apr 20222:56 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.